Dez 6, 2012 | Allgemein, company news @en, DE
British-swedish pharmaceutical company AstraZeneca intends to adjust its German corporate structure to the ever-changing economical and health policy conditions. The company plans to reduce its staff by 400 (down to 625). Affected by those measures will be internal...
Dez 4, 2012 | Allgemein, care, company news @en, DE, market knowledge
US healthcare group Baxter has taken over dialysis specialist Gambro from Swedish investment company Investor AB and private equity company EQT. For this, both associates have signed an agreement. Investor AB holds a share of 49% in Gambro since 2006. Formerly, Gambro...
Dez 4, 2012 | Allgemein, company news @en, DE, general conditions, health policy
With the consultation fee falling short as of 2013, health insurers are now afraid that compensatory financing from the national health fund will not compensate for the lack of funds. Siemens Betriebskrankenkasse (Siemens‘ company health insurace fund) advises...
Dez 4, 2012 | Allgemein, company news @en, DE
Insurance companies Axa, Gothaer and Hausärztliche Vertragsgemeinschaft (HÄVG), an organisation managing the contracts for the German Association of General Practitioners, drew a first conclusion after starting their nationwide cooperation three months ago. Thus, the...
Dez 4, 2012 | Allgemein, company news @en, DE
Medical technology company Ypsomed will supply Lifescan with needles needed for insulin pen systems. The company did not provide any information about the delivery volume. As a result, an additional manufacturing facility for needles was built within the Solothurn...
Dez 4, 2012 | Allgemein, company news @en, DE
US medical technology company Convatec has further reduced its losses in 2012. So far, the company has completed the first nine month of its 2012 fiscal year. An operational profit of $160.2m (9.9%) contributed to a reduction of debts down to $176.4m. In the same...
